Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture

gan Wrobel, Carolyn N., Debnath, Jayanta, Lin, Eva, Beausoleil, Sean, Roussel, Martine F., Brugge, Joan S.
Cyhoeddwyd 2004

A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

gan Perez, Ruth G., Waymire, Jack C., Lin, Eva, Liu, Jen J., Guo, Fengli, Zigmond, Michael J.
Cyhoeddwyd yn J Neurosci (2002)

Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition

gan Wilson, Catherine, Nicholes, Katrina, Bustos, Daisy, Lin, Eva, Song, Qinghua, Stephan, Jean-Philippe, Kirkpatrick, Donald S., Settleman, Jeff
Cyhoeddwyd 2014

Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors Through Autocrine FGFR Pathway Activation

gan Wang, Victoria E., Xue, Jenny Y., Frederick, Dennie T., Cao, Yi, Lin, Eva, Wilson, Catherine, Urisman, Anatoly, Carbone, David P., Flaherty, Keith T., Bernards, Rene, Lito, Piro, Settleman, Jeff, McCormick, Frank
Cyhoeddwyd yn Clin Cancer Res (2019)

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

gan Wilson, Timothy R., Fridlyand, Jane, Yan, Yibing, Penuel, Elicia, Burton, Luciana, Chan, Emily, Peng, Jing, Lin, Eva, Wang, Yulei, Sosman, Jeff, Ribas, Antoni, Li, Jiang, Moffat, John, Sutherlin, Daniel P., Koeppen, Hartmut, Merchant, Mark, Neve, Richard, Settleman, Jeff
Cyhoeddwyd 2012

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

gan Mygland, Line, Brinch, Shoshy Alam, Strand, Martin Frank, Olsen, Petter Angell, Aizenshtadt, Aleksandra, Lund, Kaja, Solberg, Nina Therese, Lycke, Max, Thorvaldsen, Tor Espen, Espada, Sandra, Misaghian, Dorna, Page, Christian M., Agafonov, Oleg, Nygård, Ståle, Chi, Nai-Wen, Lin, Eva, Tan, Jenille, Yu, Yihong, Costa, Mike, Krauss, Stefan, Waaler, Jo
Cyhoeddwyd yn iScience (2021)

Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

gan Merchant, Mark, Moffat, John, Schaefer, Gabriele, Chan, Jocelyn, Wang, Xi, Orr, Christine, Cheng, Jason, Hunsaker, Thomas, Shao, Lily, Wang, Stephanie J., Wagle, Marie-Claire, Lin, Eva, Haverty, Peter M., Shahidi-Latham, Sheerin, Ngu, Hai, Solon, Margaret, Eastham-Anderson, Jeffrey, Koeppen, Hartmut, Huang, Shih-Min A., Schwarz, Jacob, Belvin, Marcia, Kirouac, Daniel, Junttila, Melissa R.
Cyhoeddwyd yn PLoS One (2017)

Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

gan Merchant, Mark, Moffat, John, Schaefer, Gabriele, Chan, Jocelyn, Wang, Xi, Orr, Christine, Cheng, Jason, Hunsaker, Thomas, Shao, Lily, Wang, Stephanie J., Wagle, Marie-Claire, Lin, Eva, Haverty, Peter M., Shahidi-Latham, Sheerin, Ngu, Hai, Solon, Margaret, Eastham-Anderson, Jeffrey, Koeppen, Hartmut, Huang, Shih-Min A., Schwarz, Jacob, Belvin, Marcia, Kirouac, Daniel, Junttila, Melissa R.
Cyhoeddwyd yn PLoS One (2018)